Market Overview

Acacia Subsidiary Acquires Patent on Stent Graft Technology


Acacia Research Corp (NASDAQ: ACTG) announced today that a subsidiary has
acquired a patent for stent graft technology.

“Acacia continues to increase the number of patent portfolios we control
in the medical device and diagnostics sectors,” commented Paul Ryan,
CEO. “Acacia is expanding its presence as a leader in patent licensing
for both the technology and medical technology sectors.”


Acacia Research Corporation's subsidiaries partner with inventors and
patent owners, license the patents to corporate users, and share the
revenue. Acacia Research Corporation's subsidiaries control over 200
patent portfolios, covering technologies used in a wide variety of

See full press release

Posted-In: News Guidance M&A


Related Articles (ACTG)

View Comments and Join the Discussion!